Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 1.00 |
| ▸ | CA6 | P23280 | 5/20 | 1.00 |
| ▸ | CA7 | P43166 | 5/20 | 1.00 |
| ▸ | CA9 | Q16790 | 5/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 1.00 |
| ▸ | CA2 | P00918 | 4/20 | 1.00 |
| ▸ | CA4 | P22748 | 4/20 | 1.00 |
| ▸ | CA5A | P35218 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | CA3 | P07451 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | CA1 | P00915 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.92 |
| ▸ | MEN1 | O00255 | 2/20 | 0.91 |
| ▸ | RECQL | P46063 | 2/20 | 0.91 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.91 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL181401 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Trientine SCHEMBL10917234 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Trientine SCHEMBL3840289 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL25340653 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL15797 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL25342018 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| Trientine SCHEMBL15439 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL25342922 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL581603 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 | |
| SCHEMBL28170 | 1.00 | CA12 (1.00) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3398932-B1 | METHOD FOR SELECTIVELY SYNTHESIZING CATIONIC LIPIDS | SAMYANG HOLDINGS CORP (KR) | 2021-08-11 | — | — | EP | claimed |
| US-20180346410-A1 | METHOD FOR SELECTIVELY SYNTHESIZING CATIONIC LIPIDS | SAMYANG HOLDINGS CORPORATION (KR) | 2018-12-06 | — | — | US | claimed |
| EP-3398932-A2 | METHOD FOR SELECTIVELY SYNTHESIZING CATIONIC LIPIDS | Samyang Biopharmaceuticals Corporation (KR) | 2018-11-07 | — | — | EP | claimed |
| US-20170335204-A1 | HEAVY AMINES AS HYDROGEN SULFIDE AND MERCAPTAN SCAVENGERS | ECOLAB USA INC. | 2017-11-23 | — | — | US | claimed |
| US-9340723-B2 | Catalyzed polyamine sulfide scavengers and methods of use in subterranean treatment fluids | HALLIBURTON ENERGY SERVICES, INC. (US) | 2016-05-17 | — | — | US | claimed |
| EP-2262856-B1 | HYDROGEN SULFIDE SCAVENGERS AND METHODS FOR REMOVING HYDROGEN SULFIDE FROM ASPHALT | GEN ELECTRIC (US) | 2015-04-08 | — | — | EP | claimed |
| US-20150000918-A1 | CATALYZED POLYAMINE SULFIDE SCAVENGERS AND METHODS OF USE IN SUBTERRANEAN TREATMENT FLUIDS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2015-01-01 | — | — | US | claimed |
| WO-2014209722-A1 | CATALYZED POLYAMINE SULFIDE SCAVENGERS AND METHODS OF USE IN SUBTERRANEAN TREATMENT FLUIDS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2014-12-31 | — | — | WO | claimed |
| US-8465665-B2 | Refrigerating-machine oil composition, and compressor for refrigerating machine and refrigerating apparatus each employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-06-18 | — | — | US | claimed |
| US-20110252825-A1 | REFRIGERATING-MACHINE OIL COMPOSITION, AND COMPRESSOR FOR REFRIGERATING MACHINE AND REFRIGERATING APPARATUS EACH EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-10-20 | — | — | US | claimed |
| EP-2262856-A1 | HYDROGEN SULFIDE SCAVENGERS AND METHODS FOR REMOVING HYDROGEN SULFIDE FROM ASPHALT | General Electric Company (US) | 2010-12-22 | — | — | EP | claimed |
| WO-2009120419-A1 | HYDROGEN SULFIDE SCAVENGERS AND METHODS FOR REMOVING HYDROGEN SULFIDE FROM ASPHALT | GENERAL ELECTRIC COMPANY (US) | 2009-10-01 | — | — | WO | claimed |
| US-20090242461-A1 | HYDROGEN SULFIDE SCAVENGERS AND METHODS FOR REMOVING HYDROGEN SULFIDE FROM ASPHALT | GENERAL ELECTRIC COMPANY | 2009-10-01 | — | — | US | claimed |
| US-20080053920-A1 | A scavenger selected from a 1,3,5-trisalkanylamino hexahydro-1,3,5-triazine derivative, morpholine or piperazine derivative, amine oxide, alkanolamine, or aliphatic or aromatic polyamine; drilling, production, transport, storage, and processing of crude oil, residual fuel oil including waste water | BJ SERVICES COMPANY | 2008-03-06 | — | — | US | claimed |
| US-20050238556-A1 | Contacting crude oil and residual fuel oil streams with a scavenger, 1,3,5-tris[3-(dimethylamino)propyl]hexahydro-1,3,5-triazine, a morpholine or piperazine derivative and an amide substituted amine oxide | BAKER HUGHES HOLDINGS LLC | 2005-10-27 | — | — | US | claimed |
| EP-3695850-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A NEGATIVELY CHARGED DRUG AND A CATIONIC LIPID | SAMYANG HOLDINGS CORP (KR) | 2025-05-21 | — | — | EP | disclosed |
| US-20230332064-A1 | LUBRICATING OIL COMPOSITION | ENEOS CORPORATION (JP) | 2023-10-19 | — | — | US | disclosed |
| US-5284576-A | Method of scavenging hydrogen sulfide from hydrocarbons | PETROLITE CORPORATION (US) | 1994-02-08 | — | — | US | disclosed |
| EP-0411745-A1 | Method of scavenging hydrogen sulfide from hydrocarbons | PETROLITE CORPORATION (US) | 1991-02-06 | — | — | EP | disclosed |
| US-4877578-A | REACTION PRODUCT OF ALKYLENEPOLYAMINE AND FORMALDEHYDE | PETROLITE CORPORATION (US) | 1989-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180346410-A1 | METHOD FOR SELECTIVELY SYNTHESIZING CATIONIC LIPIDS | LIPA, LIPC, FASN | CA12 1491/4885CA6 1293/4885CA7 1378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.